CLINICAL_TRIALS
trial_result
· 2022-10-18
Clinical Trial Update: A Study of LY2140023 in Patients With Schizophrenia [Phase 3]
Summary
Phase 3 clinical trial update for LY2140023 in schizophrenia; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Denovo Biopharma LLC | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED | Results posted: 2022-10-18